Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE2.1300
- TODAY'S CHANGE (%)-0.0600 (-2.7397%)
- Bid / Lots1.9900/ 6
- Ask / Lots2.3600/ 1
- Open / Previous Close2.1200 / 2.1900
- Day Range
- 52 Week Range
- Volume706,910
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 126301 | 2.12 |
| 09:34 ET | 300 | 2.13 |
| 09:36 ET | 1414 | 2.14 |
| 09:39 ET | 1919 | 2.14 |
| 09:41 ET | 6000 | 2.15 |
| 09:48 ET | 200 | 2.13 |
| 09:50 ET | 2900 | 2.11 |
| 09:52 ET | 1150 | 2.09 |
| 09:54 ET | 6400 | 2.1 |
| 09:57 ET | 829 | 2.11 |
| 09:59 ET | 11097 | 2.13 |
| 10:01 ET | 200 | 2.145 |
| 10:03 ET | 100 | 2.145 |
| 10:08 ET | 600 | 2.14 |
| 10:12 ET | 600 | 2.13 |
| 10:15 ET | 2219 | 2.13 |
| 10:17 ET | 550 | 2.15 |
| 10:19 ET | 168 | 2.155 |
| 10:24 ET | 400 | 2.16 |
| 10:28 ET | 2400 | 2.16 |
| 10:30 ET | 100 | 2.16 |
| 10:32 ET | 4955 | 2.18 |
| 10:33 ET | 420 | 2.18 |
| 10:35 ET | 100 | 2.18 |
| 10:39 ET | 100 | 2.19 |
| 10:42 ET | 100 | 2.19 |
| 10:44 ET | 200 | 2.18 |
| 10:48 ET | 200 | 2.19 |
| 10:50 ET | 100 | 2.18 |
| 10:51 ET | 1200 | 2.18 |
| 10:55 ET | 100 | 2.17 |
| 11:02 ET | 900 | 2.16 |
| 11:04 ET | 500 | 2.14 |
| 11:08 ET | 400 | 2.1577 |
| 11:09 ET | 100 | 2.14 |
| 11:13 ET | 933 | 2.131 |
| 11:24 ET | 100 | 2.13 |
| 11:27 ET | 500 | 2.13 |
| 11:31 ET | 100 | 2.13 |
| 11:33 ET | 4925 | 2.125 |
| 11:36 ET | 1913 | 2.13 |
| 11:38 ET | 100 | 2.135 |
| 11:42 ET | 1100 | 2.135 |
| 11:44 ET | 578 | 2.15 |
| 11:45 ET | 1200 | 2.1538 |
| 11:47 ET | 100 | 2.15 |
| 11:51 ET | 100 | 2.146 |
| 11:54 ET | 400 | 2.14 |
| 11:58 ET | 200 | 2.16 |
| 12:00 ET | 200 | 2.165 |
| 12:02 ET | 200 | 2.17 |
| 12:07 ET | 400 | 2.16 |
| 12:09 ET | 400 | 2.165 |
| 12:12 ET | 424 | 2.17 |
| 12:14 ET | 300 | 2.16 |
| 12:16 ET | 200 | 2.16 |
| 12:20 ET | 300 | 2.15 |
| 12:23 ET | 100 | 2.145 |
| 12:27 ET | 100 | 2.145 |
| 12:34 ET | 200 | 2.15 |
| 12:38 ET | 200 | 2.14 |
| 12:39 ET | 2800 | 2.145 |
| 12:41 ET | 800 | 2.145 |
| 12:45 ET | 100 | 2.145 |
| 12:50 ET | 200 | 2.145 |
| 12:52 ET | 1100 | 2.16 |
| 12:54 ET | 100 | 2.155 |
| 12:56 ET | 900 | 2.155 |
| 12:59 ET | 100 | 2.16 |
| 01:01 ET | 200 | 2.155 |
| 01:06 ET | 617 | 2.15 |
| 01:08 ET | 400 | 2.15 |
| 01:12 ET | 100 | 2.16 |
| 01:14 ET | 1146 | 2.16 |
| 01:15 ET | 1812 | 2.165 |
| 01:17 ET | 700 | 2.18 |
| 01:19 ET | 747 | 2.18 |
| 01:21 ET | 726 | 2.18 |
| 01:24 ET | 1100 | 2.175 |
| 01:26 ET | 500 | 2.175 |
| 01:28 ET | 1437 | 2.19 |
| 01:30 ET | 1100 | 2.19 |
| 01:32 ET | 1500 | 2.19 |
| 01:33 ET | 865 | 2.19 |
| 01:35 ET | 4437 | 2.19 |
| 01:37 ET | 900 | 2.2 |
| 01:39 ET | 590 | 2.195 |
| 01:42 ET | 1865 | 2.195 |
| 01:44 ET | 357 | 2.2 |
| 01:46 ET | 522 | 2.195 |
| 01:48 ET | 500 | 2.2 |
| 01:50 ET | 478 | 2.2 |
| 01:51 ET | 742 | 2.2 |
| 01:53 ET | 800 | 2.2 |
| 01:55 ET | 4619 | 2.2 |
| 01:57 ET | 1642 | 2.21 |
| 02:00 ET | 2000 | 2.2 |
| 02:02 ET | 913 | 2.2 |
| 02:04 ET | 800 | 2.22 |
| 02:06 ET | 628 | 2.22 |
| 02:08 ET | 1483 | 2.22 |
| 02:09 ET | 3000 | 2.2 |
| 02:11 ET | 1400 | 2.21 |
| 02:13 ET | 500 | 2.21 |
| 02:15 ET | 1726 | 2.2 |
| 02:18 ET | 1123 | 2.19 |
| 02:20 ET | 500 | 2.2 |
| 02:22 ET | 839 | 2.2 |
| 02:24 ET | 800 | 2.2 |
| 02:26 ET | 336 | 2.2 |
| 02:27 ET | 2036 | 2.1859 |
| 02:29 ET | 869 | 2.19 |
| 02:31 ET | 300 | 2.2 |
| 02:33 ET | 490 | 2.19 |
| 02:36 ET | 800 | 2.19 |
| 02:38 ET | 420 | 2.19 |
| 02:40 ET | 1161 | 2.2 |
| 02:42 ET | 550 | 2.2 |
| 02:44 ET | 1491 | 2.21 |
| 02:45 ET | 1938 | 2.22 |
| 02:47 ET | 700 | 2.21 |
| 02:49 ET | 540 | 2.22 |
| 02:51 ET | 1432 | 2.21 |
| 02:54 ET | 1100 | 2.22 |
| 02:56 ET | 900 | 2.21 |
| 02:58 ET | 500 | 2.21 |
| 03:00 ET | 500 | 2.21 |
| 03:02 ET | 800 | 2.22 |
| 03:03 ET | 1800 | 2.21 |
| 03:05 ET | 1455 | 2.21 |
| 03:07 ET | 690 | 2.22 |
| 03:09 ET | 4540 | 2.21 |
| 03:12 ET | 1013 | 2.21 |
| 03:14 ET | 1000 | 2.21 |
| 03:16 ET | 600 | 2.22 |
| 03:18 ET | 1100 | 2.22 |
| 03:20 ET | 1100 | 2.21 |
| 03:21 ET | 500 | 2.21 |
| 03:23 ET | 448 | 2.22 |
| 03:25 ET | 5000 | 2.195 |
| 03:27 ET | 300 | 2.2 |
| 03:30 ET | 714 | 2.22 |
| 03:32 ET | 400 | 2.22 |
| 03:34 ET | 3333 | 2.225 |
| 03:36 ET | 846 | 2.225 |
| 03:38 ET | 11222 | 2.195 |
| 03:39 ET | 1100 | 2.2 |
| 03:41 ET | 300 | 2.21 |
| 03:43 ET | 1400 | 2.21 |
| 03:45 ET | 1000 | 2.21 |
| 03:48 ET | 1493 | 2.195 |
| 03:50 ET | 4212 | 2.175 |
| 03:52 ET | 2700 | 2.165 |
| 03:54 ET | 609 | 2.17 |
| 03:56 ET | 6308 | 2.155 |
| 03:57 ET | 2431 | 2.145 |
| 03:59 ET | 173524 | 2.13 |
Sep 3, 2024
Tenaya Therapeutics to Participate in Upcoming Investment Conferences, from 8:30AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:30AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 172.8M | -1.4x | --- |
DiaMedica Therapeutics Inc | 172.7M | -7.9x | --- |
Immunic Inc | 175.7M | -1.2x | --- |
Galectin Therapeutics Inc | 176.9M | -3.5x | --- |
Ventyx Biosciences Inc | 167.5M | -0.8x | --- |
Context Therapeutics Inc | 167.2M | -2.1x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Director
- Faraz Ali
- Chief Medical Officer
- Whittemore Tingley
- Independent Director
- Amy Burroughs
- Independent Director
- June Lee
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $172.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.54 |
Book Value | $2.04 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
